Dimensional Fund Advisors' $477B Q4 2025 Filing Spreads Across 3,239 Positions With No Stock Above 3.7%
DFA held $476.7B in Q4 2025 across 3,239 unique holdings — the broadest active manager in the top 50. No single stock exceeds 3.7%, making this the anti-concentration 13F among major filers.
Dimensional Fund Advisors filed its Q4 2025 13F showing $476.7 billion across 3,239 unique holdings. The largest position, Nvidia, accounts for just 3.68% of the portfolio. No stock exceeds 4%. In a world where concentrated conviction bets dominate the headlines, DFA runs the opposite playbook: systematic, factor-based diversification at massive scale.
TL;DR
- AUM: $476.7B (Q4 2025)
- Holdings count: 3,239 unique — broadest active manager in the top 50
- Max position weight: 3.68% (Nvidia) — the lowest max-weight among top-30 filers
- Top-5 concentration: 12.6% — far below the 16-25% range of peers
- Factor approach: DFA's signature systematic value/small-cap tilts visible in the breadth
- Healthcare presence: Eli Lilly ($4.1B, 0.85%) and Johnson & Johnson ($3.6B, 0.75%) in top 12
- Berkshire at #12: BRK/B at $3.6B (0.75%) — Buffett's conglomerate fits the value factor tilt
- Whale Score: 69.00
DFA Top 12 Holdings — Q4 2025 ($B)
The Anti-Concentration Strategy
DFA's 3,239 positions with a 3.68% maximum weight is fundamentally different from peers like Capital International (454 holdings, 7.7% top weight) or Capital Research Global (434 holdings, 6.55% top weight). DFA's approach is rooted in academic finance: diversify across factors (value, size, profitability) rather than concentrating in individual names.
The top-5 (NVDA 3.68%, AAPL 3.28%, MSFT 2.69%, AMZN 1.54%, META 1.39%) totals just 12.6% — the lowest among any top-30 filer. Even passive index funds like Vanguard show higher concentration because they weight purely by market cap.
The Value Factor Footprint
JPMorgan at $5.9B (1.24%) and Berkshire Hathaway at $3.6B (0.75%) in the top 12 reflect DFA's value tilt. Both are classic value names that systematic factor portfolios overweight relative to pure market-cap indexing. Johnson & Johnson ($3.6B, 0.75%) adds defensive quality — another DFA factor preference.
DFA Top-5 Concentration vs Peers (% of Portfolio)
What Analysts Might Misread
Misread #1: “Low concentration means no conviction”
DFA's conviction is expressed through factor exposures, not individual stock bets. The portfolio is deliberately diversified — that IS the strategy, not a lack of one.
Misread #2: “DFA is just another index fund”
DFA is not an index fund. It uses proprietary factor models to tilt toward value, small-cap, and high-profitability stocks. The result looks like an index but weights are systematically different from any standard benchmark.
Frequently Asked Questions
What is Dimensional Fund Advisors' investment approach?
DFA uses systematic, factor-based investing rooted in academic research. Portfolios tilt toward value, small-cap, and profitability factors rather than concentrating in individual stocks.
How concentrated is DFA's portfolio?
Minimal. The top holding (Nvidia) is just 3.68%, and the top-5 total 12.6%. With 3,239 positions, DFA is the broadest active manager among top-50 filers.
What is DFA's AUM?
$476.7 billion in 13F AUM as of Q4 2025 across 3,239 unique holdings.
Related Research
Explore all researchCapital International Investors grew to $638B across just 454 holdings in Q4 2025. Broadcom leads at 7.7% ($49.1B), making this one of the most concentrated mega-filer portfolios on record.
Mar 10, 2026
UK's largest asset manager held $450.9B in Q4 2025 with Nvidia at 7.09% and Apple at 6.66%. The top-3 concentration of 19.3% is notably higher than comparable diversified managers.
Mar 10, 2026
Ameriprise held $442.5B across 4,016 positions in Q4 2025. Lam Research at #11 ($4.0B, 0.90%) stands out — a semiconductor equipment name that rarely appears in wealth management platform top-12s.
Mar 10, 2026
Wells Fargo's Q4 2025 13F shows $549.1B across 6,616 holdings. Four ETFs (SPY, IVV, QQQ, ITOT) account for $53.8B — a 9.7% allocation to index wrappers that dwarfs the individual stock positions below.
Mar 10, 2026
Wellington Management held $570.7B across 1,878 positions in Q4 2025. Eli Lilly and Merck sit at #7 and #8, giving healthcare a 4.1% share of the top-12 — unusual for a fund this size.
Mar 10, 2026